Fluvastatin
From Wikipedia, the free encyclopedia
![]() |
|
|---|---|
| Systematic (IUPAC) name | |
| (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | |
| Clinical data | |
| Trade names | Lescol |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a694010 |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Pharmacokinetic data | |
| Protein binding | 98% |
| Half-life | 2.5 hours |
| Identifiers | |
| CAS number | 93957-54-1 |
| ATC code | C10AA04 |
| PubChem | CID 446155 |
| DrugBank | APRD00346 |
| ChemSpider | 393587 |
| UNII | 4L066368AS |
| KEGG | D07983 |
| ChEBI | CHEBI:38565 |
| ChEMBL | CHEMBL1078 |
| Chemical data | |
| Formula | C24H26FNO4 |
| Mol. mass | 411.466 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Fluvastatin (trade names Lescol, Canef, Vastin) is a member of the drug class of statins, used to treat hypercholesterolemia and to prevent cardiovascular disease.
It has also been shown to exhibit antiviral activity against Hepatitis C in a study with 31 patients. This effect has been described as modest, variable, and often short-lived by the authors.[1]
[edit] References
- ^ Bader T, Fazili J, Madhoun M, et al. (April 2008). "Fluvastatin Inhibits Hepatitis C Replication in Humans". Am. J. Gastroenterol. 103 (6): 1383. doi:10.1111/j.1572-0241.2008.01876.x. PMID 18410471.
|
||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
